Treatment of advanced myelodysplastic syndromes with recombinant interferon-alpha2b

This publication has 21 references indexed in Scilit:

• Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors
  British Journal of Haematology, 1990
• Therapeutic effects of low‐dose cytosine arabinoside, alpha‐interferon, 1α‐hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromes
  European Journal of Haematology, 1988
• Disappearance of Trisomy 8 after Alpha-2 Interferon in a Patient with Myelodysplastic Syndrome
  New England Journal of Medicine, 1988
• α-INTERFERON IN MYELODYSPLASIA
  British Journal of Haematology, 1987
• Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases
  British Journal of Haematology, 1987
• Myelodysplastic syndromes: a study of 101 cases according to the FAB classification
  British Journal of Haematology, 1985
• Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases
  Cancer, 1985
• Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis
  British Journal of Haematology, 1985
• Close link between reduction of c-myc expression by interferon and G0/G1 arrest
  Nature, 1985
• Growth inhibitory effects of interferon on normal and malignant human haemopoietic cells
  International Journal of Cancer, 1977